Trasis

𝐈𝐧𝐧𝐨𝐯𝐞𝐫 𝐩𝐨𝐮𝐫 𝐬𝐚𝐮𝐯𝐞𝐫 𝐝𝐞𝐬 𝐯𝐢𝐞𝐬, 𝐜’𝐞𝐬𝐭 𝐮𝐧 𝐝𝐞́𝐟𝐢 𝐜𝐨𝐥𝐥𝐞𝐜𝐭𝐢𝐟. 𝐀𝐮𝐣𝐨𝐮𝐫𝐝’𝐡𝐮𝐢, 𝐧𝐨𝐮𝐬 𝐚𝐯𝐨𝐧𝐬 𝐛𝐞𝐬𝐨𝐢𝐧 𝐝𝐞 𝐯𝐨𝐮𝐬. Notre CEO, Gauthier Philippart, est nominé pour le Liégeois de l’Année. Il rejoint d’autres patrons liégeois inspirants dans la catégorie économique et défend les couleurs de Trasis, société belge leader mondial dans le domaine de la médecine nucléaire. Ce qui le motive ? Contribuer à une ambition collective, repousser les limites de la médecine nucléaire et explorer sans relâche de nouvelles solutions pour améliorer le diagnostic et le traitement des cancers et maladies dégénératives 💪 Sa nomination est déjà une belle reconnaissance pour toute l’équipe Trasis, près de 400 personnes engagées au quotidien à Ans, qui partagent cette même vision et cette envie d’innover pour faire avancer la médecine. Aidez-nous à relever ce nouveau challenge : votez pour Gauthier comme liégeois de l’année ! (catégorie économique). 👉 Ça se passe ici, en quelques clics : https://lnkd.in/eivq4Y5h Merci pour votre soutien ! #liegeoisdelannée #liege #lifesciences #entrepreneuriat 🙏🏻 Sudinfo Moovizz Studios Maximum Fm

𝗠𝗲𝗲𝘁 𝗧𝗿𝗮𝘀𝗶𝘀 𝗮𝘁 𝗦𝗼𝗶𝗿𝗲́𝗲 𝗦𝘁𝗮𝗴𝗲 & 𝗖𝗮𝗿𝗲𝗲𝗿𝘀 𝗳𝗼𝗿 𝗖𝗵𝗲𝗺𝗶𝘀𝘁𝗿𝘆 𝗕𝗮𝗰𝗵𝗲𝗹𝗼𝗿 𝗦𝘁𝘂𝗱𝗲𝗻𝘁𝘀 (𝗛𝗘𝗣𝗟) & 𝗛𝗘𝗟𝗠𝗼 𝗝𝗼𝗯 𝗗𝗮𝘆 𝟮𝟬𝟮𝟱 𝗘́𝗰𝗼 & 𝗧𝗲𝗰𝗵 𝘁𝗼𝗱𝗮𝘆! Our team is on-site today! Don't hesitate to drop by, say hello, and explore exciting career opportunities with Trasis. Whether you're looking for an internship, a first job, or just career advice, we're here to answer your questions! 📍 Come meet us and let's talk about your future!

𝗔 𝗴𝗿𝗲𝗮𝘁 𝗺𝗲𝗲𝘁𝗶𝗻𝗴 𝗮𝘁 𝗧𝗿𝗮𝘀𝗶𝘀 𝘄𝗶𝘁𝗵 𝘁𝗵𝗲 𝗝𝗼𝗯 𝗗𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆 𝗰𝗮𝗻𝗱𝗶𝗱𝗮𝘁𝗲𝘀! A big thank you to Live in Color Association for this promising partnership and to the candidates for their enthusiasm!

𝗧𝗼𝗱𝗮𝘆, 𝗻𝘂𝗰𝗹𝗲𝗮𝗿 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗽𝗹𝗮𝘆𝘀 𝗮 𝗸𝗲𝘆 𝗿𝗼𝗹𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝗶𝘀 𝗮𝗻𝗱 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗼𝗳 𝗰𝗮𝗻𝗰𝗲𝗿 𝗮𝗻𝗱 𝗻𝗲𝘂𝗿𝗼𝗱𝗲𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝘃𝗲 𝗱𝗶𝘀𝗲𝗮𝘀𝗲𝘀. To achieve this, it is essential that patients receive a precise dose of the most effective radiotracer for their condition, in a safe manner. We have therefore designed several synthesizers dedicated to the automated preparation and dispensing of radiopharmaceuticals. Each has its own specific features to provide a complementary range of solutions for the medical community while ensuring its safety. At the JFMN, we will present three of our solutions, including two new innovations. Discover them here! https://lnkd.in/eJT5xD-3 And do not hesitate to visit us at booth No. 9H ! 

🎓𝗥𝗲𝗮𝗱𝘆 𝘁𝗼 𝗺𝗮𝗸𝗲 𝗮 𝗿𝗲𝗮𝗹 𝗶𝗺𝗽𝗮𝗰𝘁? 𝗠𝗲𝗲𝘁 𝗧𝗿𝗮𝘀𝗶𝘀 𝘀𝗼𝗼𝗻 𝗮𝘁 𝗱𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁 𝗷𝗼𝗯 𝗱𝗮𝘆𝘀 ! At Trasis, we’re dedicated to making a difference in nuclear medicine by supporting the fight against cancer and neurodegenerative diseases. Our work helps ensure that life-changing treatments reach those who need them most. We’re excited to connect with curious minds and passionate individuals ready to grow with us. 📅 𝗪𝗵𝗲𝗿𝗲 𝘁𝗼 𝗳𝗶𝗻𝗱 𝘂𝘀: 𝗝𝗼𝘂𝗿𝗻𝗲́𝗲𝘀 𝗱𝗲 𝗹'𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝗶𝗲 𝗨𝗖𝗟𝗼𝘂𝘃𝗮𝗶𝗻 – March 3  𝗙𝗼𝗿𝘂𝗺 𝗘𝗻𝘁𝗿𝗲𝗽𝗿𝗶𝘀𝗲𝘀 𝗨𝗟𝗶𝗲̀𝗴𝗲 – March 10  𝗝𝗼𝗯 𝗗𝗮𝘆 𝗘𝗰𝗼 & 𝗧𝗲𝗰𝗵 𝗛𝗲𝗹𝗺𝗼 – March 13  𝗦𝗼𝗶𝗿𝗲́𝗲 𝗦𝘁𝗮𝗴𝗲 𝗮𝗻𝗱 𝗖𝗮𝗿𝗲𝗲𝗿𝘀 𝗳𝗼𝗿 𝗖𝗵𝗲𝗺𝗶𝘀𝘁𝗿𝘆 𝗕𝗮𝗰𝗵𝗲𝗹𝗼𝗿 𝗦𝘁𝘂𝗱𝗲𝗻𝘁𝘀 𝗛𝗘𝗣𝗟 – March 13  𝗖𝗮𝗿𝗲𝗲𝗿 𝗡𝗶𝗴𝗵𝘁 𝗛𝗘𝗖 𝗟𝗶𝗲̀𝗴𝗲 – March 26  𝗝𝗼𝗯𝘀 𝗗𝗮𝘆 𝗖𝗵𝗶𝗺𝗶𝗲, 𝗣𝗵𝗮𝗿𝗺𝗮, 𝗛𝗲𝗮𝗹𝘁𝗵 & 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗘𝘀𝘀𝗲𝗻𝗰𝗶𝗮 – April 9 💬 Come chat with us about internships, jobs, or simply to learn more about what we do. 👉 Want to know more? Check out our career page: https://lnkd.in/eEvF2tRh We look forward to meeting you!  Maxime Degbomont Manon Vandermissen Vincent Theunissen

𝗪𝗲 𝗮𝗿𝗲 𝗽𝗹𝗲𝗮𝘀𝗲𝗱 𝘁𝗼 𝗽𝗿𝗲𝘀𝗲𝗻𝘁 𝗘𝗮𝘀𝘆𝗢𝗻𝗲 𝗖𝗼𝗹𝗱 𝗞𝗶𝘁𝘀 𝗟𝗮𝗯𝗲𝗹𝗶𝗻𝗴 & 𝗗𝗶𝘀𝗽𝗲𝗻𝘀𝗶𝗻𝗴, 𝘁𝗵𝗲 𝗳𝗶𝗿𝘀𝘁 𝗮𝘂𝘁𝗼𝗺𝗮𝘁𝗲𝗱 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗳𝗼𝗿 𝗚𝗮-𝟲𝟴 𝗰𝗼𝗹𝗱 𝗸𝗶𝘁𝘀 𝗹𝗮𝗯𝗲𝗹𝗹𝗶𝗻𝗴 𝗮𝗻𝗱 𝗱𝗼𝘀𝗲 𝗽𝗿𝗲𝗽𝗮𝗿𝗮𝘁𝗶𝗼𝗻. This advancement has been specifically designed to improve: - 𝗦𝘁𝗮𝗳𝗳 𝗿𝗮𝗱𝗶𝗮𝘁𝗶𝗼𝗻 𝗽𝗿𝗼𝘁𝗲𝗰𝘁𝗶𝗼𝗻 – Reducing operator finger exposure by 75% (study conducted at St. Louis Hospital, AP-HP). - 𝗛𝗶𝗴𝗵 𝗽𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗮𝗻𝗱 𝗿𝗲𝗽𝗿𝗼𝗱𝘂𝗰𝗶𝗯𝗶𝗹𝗶𝘁𝘆  – Ensuring consistent and accurate dose preparation. - 𝗦𝗶𝗴𝗻𝗶𝗳𝗶𝗰𝗮𝗻𝘁 𝘁𝗶𝗺𝗲 𝘀𝗮𝘃𝗶𝗻𝗴𝘀 – Up to four times faster than conventional manual preparation. - 𝗦𝘁𝗿𝗶𝗰𝘁 𝗰𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝘄𝗶𝘁𝗵 𝗿𝗮𝗱𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝘀𝘁𝗮𝗻𝗱𝗮𝗿𝗱𝘀 – Guaranteeing regulatory adherence and process reliability. For this innovative solution, we are privileged to collaborate with 𝗗𝗿. 𝗝𝘂𝗹𝗶𝗲𝗻 𝗙𝗼𝘂𝗾𝘂𝗲, radiopharmacist at 𝗜𝗻𝘀𝘁𝗶𝘁𝘂𝘁 𝗖𝘂𝗿𝗶𝗲, who has successfully implemented 𝗘𝗮𝘀𝘆𝗢𝗻𝗲 𝗖𝗼𝗹𝗱 𝗞𝗶𝘁𝘀 𝗟𝗮𝗯𝗲𝗹𝗶𝗻𝗴 & 𝗗𝗶𝘀𝗽𝗲𝗻𝘀𝗶𝗻𝗴 in clinical practice. According to Dr. Julien Fouque: "The automation provided by Trasis equipment ensures the reliability of radiopharmaceutical preparation and dispensing processes while enhancing operator safety." Together, we will present 𝗮 𝘀𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝗼𝗻 𝗠𝗮𝗿𝗰𝗵 𝟮𝟬 𝗮𝘁 𝟭𝟭:𝟯𝟬 𝗔𝗠, where we will discuss 𝘁𝗵𝗲 𝗯𝗲𝗻𝗲𝗳𝗶𝘁𝘀 𝗮𝗻𝗱 𝗿𝗲𝗮𝗹-𝘄𝗼𝗿𝗹𝗱 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲 of the EasyOne Cold Kits solution for healthcare teams and patients. 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝘁𝗵𝗶𝘀 𝗯𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 : https://lnkd.in/ekPyrvci

𝗧𝗲𝘀𝘁𝗶𝗺𝗼𝗻𝗶𝗮𝗹✨ At Trasis, we continuously improve our equipment and design new ones to constantly enhance radiation protection for medical personnel, making the most of the opportunities offered by nuclear medicine.    After using the Unidose, the Centre d'Imagerie Isotopique Lorrain (CIIL) - Centre Jacques Callot, confirms that it has reduced the radiation exposure of its operators by 57% while guaranteeing procedures as precise and reliable as ever. 🔗 More about our solution : https://lnkd.in/esmgVmD5 ✉️ For any questions, contact us at: bu-hospital@trasis.com

𝗪𝗲 𝗮𝗿𝗲 𝘁𝗵𝗿𝗶𝗹𝗹𝗲𝗱 𝘁𝗼 𝗮𝗻𝗻𝗼𝘂𝗻𝗰𝗲 𝘁𝗵𝗮𝘁 𝘁𝗵𝗲 𝗧𝗿𝗮𝘀𝗶𝘀 [𝟭𝟴𝗙]𝗙𝗗𝗚 𝗗𝘂𝗮𝗹+/𝗤𝘂𝗮𝗱 𝗺𝗲𝘁𝗵𝗼𝗱𝘀 𝗵𝗮𝘃𝗲 𝗯𝗲𝗲𝗻 𝗼𝗳𝗳𝗶𝗰𝗶𝗮𝗹𝗹𝘆 𝗙𝗗𝗔-𝗮𝗽𝗽𝗿𝗼𝘃𝗲𝗱 𝗳𝗼𝗿 𝘂𝘀𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗨𝗻𝗶𝘁𝗲𝗱 𝗦𝘁𝗮𝘁𝗲𝘀 𝗮𝘀 𝗼𝗳 𝗗𝗲𝗰𝗲𝗺𝗯𝗲𝗿 𝟮𝟬𝟮𝟰 — 𝗮 𝗺𝗶𝗹𝗲𝘀𝘁𝗼𝗻𝗲 𝗰𝗼𝗻𝗳𝗶𝗿𝗺𝗲𝗱 𝗯𝘆 𝗼𝘂𝗿 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝘁𝗲𝗮𝗺. This achievement marks a significant step forward, with our customer, Queens Medical Center, already initiating routine production of [18F]FDG using both FDG Dual+ and FDG Quad methods in recent weeks, ensuring broader access to this essential imaging agent. 🔬 [18F]FDG is a key player in molecular imaging, enabling the study of cellular carbohydrate metabolism. It remains a cornerstone in oncology, particularly for initial diagnosis and recurrence monitoring. 👏 This FDA approval is the result of hard work, precision, and dedication from our teams. Bringing [18F]FDG to more patients, reliably and efficiently, is what drives us. This milestone is a step forward—not just for Trasis, but for everyone working to improve molecular imaging. A sincere thank you to all who made it happen.   Charles Vriamont Emmanuel (Manu) Bertrand #MolecularImaging #Radiopharmaceuticals #FDG #Oncology 

𝗧𝗥𝗔𝗦𝗜𝗦 𝗻𝗼𝗺𝗶𝗻𝗮𝘁𝗲𝗱 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗧𝗿𝗲𝗻𝗱𝘀 𝗚𝗮𝘇𝗲𝗹𝗹𝗲𝘀 𝟮𝟬𝟮𝟱!  🙌 We’ve just received the news: Trends Gazelles has selected Trasis in the category of fast-growing companies in the Liège province. A jury will now deliberate, and we’ll know more during the ceremony on March 26th! We’ll keep you posted! 😉 

𝗪𝗲 𝗵𝗮𝗱 𝘁𝗵𝗲 𝗰𝗵𝗮𝗻𝗰𝗲 𝘁𝗼 𝘄𝗲𝗹𝗰𝗼𝗺𝗲 𝘁𝗵𝗲 𝗚𝗥𝗗 𝗡𝗲𝘁𝘄𝗼𝗿𝗸 𝗮𝘁 𝗧𝗿𝗮𝘀𝗶𝘀 ! 🍀 The GRD Network gathers once every few months to foster cross-industry innovations, share experiences and best practices, and discuss R&D-related topics. As usual, innovation and R&D have sparked exciting discussions, further demonstrating their importance across all sectors!